Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine.
Clin Cancer Res. 2022 Dec 15;28(24):5306-5316. doi: 10.1158/1078-0432.CCR-22-1810.
Clin Cancer Res. 2022.
PMID: 36222848
Free PMC article.
Clinical Trial.
Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: a multicenter trial of the AIDS Malignancy Consortium.
Brinker BT, Krown SE, Lee JY, Cesarman E, Chadburn A, Kaplan LD, Henry DH, Von Roenn JH.
Brinker BT, et al.
Cancer. 2008 Mar 1;112(5):1083-8. doi: 10.1002/cncr.23108.
Cancer. 2008.
PMID: 18224669
Free article.
Clinical Trial.
Item in Clipboard
Effect of single agent high-dose methotrexate-related acute kidney injury on length of hospitalization and relative dose intensity in adult patients with central nervous system lymphoma.
Steward JS, Bullard HM, O'Rourke TJ, Campbell AD, Brinker BT, Yost KJ, Vanderwoude AC, Scott WL, Kintzel PE.
Steward JS, et al. Among authors: brinker bt.
J Oncol Pharm Pract. 2017 Oct;23(7):496-501. doi: 10.1177/1078155216665244. Epub 2016 Aug 19.
J Oncol Pharm Pract. 2017.
PMID: 27543094
Item in Clipboard
Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma.
Brinker BT, Waller EK, Leong T, Heffner LT Jr, Redei I, Langston AA, Lonial S.
Brinker BT, et al.
Cancer. 2006 May 15;106(10):2171-80. doi: 10.1002/cncr.21852.
Cancer. 2006.
PMID: 16598756
Free article.
Item in Clipboard
Reduced time for urinary alkalinization before high-dose methotrexate with preadmission oral bicarbonate.
Kintzel PE, Campbell AD, Yost KJ, Brinker BT, Arradaza NV, Frobish D, Wehr AM, O'Rourke TJ.
Kintzel PE, et al. Among authors: brinker bt.
J Oncol Pharm Pract. 2012 Jun;18(2):239-44. doi: 10.1177/1078155211426913. Epub 2011 Nov 10.
J Oncol Pharm Pract. 2012.
PMID: 22075004
Item in Clipboard
Phase II study of concurrent radiation therapy, temozolomide, and bevacizumab followed by bevacizumab/everolimus as first-line treatment for patients with glioblastoma.
Hainsworth JD, Shih KC, Shepard GC, Tillinghast GW, Brinker BT, Spigel DR.
Hainsworth JD, et al. Among authors: brinker bt.
Clin Adv Hematol Oncol. 2012 Apr;10(4):240-6.
Clin Adv Hematol Oncol. 2012.
PMID: 22706484
Clinical Trial.
Item in Clipboard
Cite
Cite